Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
This NIH cooperative agreement funds recruitment sites to enroll AKI and CKD participants into the Kidney Precision Medicine Project longitudinal biopsy cohort, including biopsies, phenotyping, and related participant recruitment activities.
⚑ U01 cooperative agreement · Clinical Trial Not Allowed · foreign organizations and foreign components are not allowed · award ceiling $450,000
Unit fits — one characterization, each unit's own rules
| Physical Sciences & Engineering (demo) | 80 strong | technical depth: substantial; funds data infrastructure |
| IPPRA | 58 good | portfolio topic: public_health; social/behavioral work is minor; funds data/survey infrastructure; clinical-trial/biomedical core — IPPRA angle is policy/community (capped) |
| Tom Love Innovation Hub | 15 none | deep-tech content; no commercialization signal |
Description
This Notice of Funding Opportunity (NOFO) requests applications for Kidney Precision Medicine Project (KPMP) Recruitment Sites (RS) to enroll people with Acute Kidney Injuries (AKI) and/or Chronic Kidney Diseases (CKD) into a longitudinal biopsy cohort study. Under-enrolled populations (e.g., AKI) and comprehensive phenotyping remain priorities. New opportunities include clinical biopsies with residual tissue for research, enhanced physiologic phenotyping, repeat biopsies, pediatric recruitment, and collection of healthy reference tissue. All KPMP personnel will actively participate in scientific discovery and promote open science.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply
View on Grants.gov → CONTACT: National Institutes of Health <NIDDK_KUH@nih.gov>
Proposal brief
Proposal shell · National Institutes of Health conventions
Legacy IPPRA LLM assessment (v2.0, for comparison)
18/100 · gpt-5.4-mini · 2026-07-06
This is a biomedical clinical-cohort recruitment opportunity for kidney disease, focused on enrollment, biopsies, and phenotyping rather than policy, behavioral, or community-based research. IPPRA’s strengths in health communication or program evaluation are not central here, and the NOFO is limited to NIH-eligible domestic entities but is not a good fit for a public-policy research institute.
Legacy scoring history
| 2026-07-06 | 18 | gpt-5.4-mini | This is a biomedical clinical-cohort recruitment opportunity for kidney disease, focused on enrollment, biopsies, and phenotyping rather than policy, behavioral, or community-based research. IPPRA’s strengths in health communication or program evaluation are not central here, and the NOFO is limited to NIH-eligible domestic entities but is not a good fit for a public-policy research institute. |
| 2026-07-06 | 18 | gpt-5.4-mini | This is a clinical kidney-disease recruitment and biopsy cohort opportunity, with little connection to IPPRA’s core strengths in risk communication, behavioral intervention, or policy analysis. While it sits in the broad public health domain, it is predominantly biomedical/clinical research and not a strong fit for IPPRA’s social-science or community-facing portfolio. Public universities appear eligible, but the topic is too technical and not policy/behavior centered, so the fit remains weak. |